Table 1.

Overview of the rate of older APL patients included in multicenter trials with ATRA and chemotherapy

Author (year) [reference]	Number of patients	Age (years), median (range)	≥60 years (%)	≥70 years (%)	Total patients with high risk (%)
Kanamaru (1995) [15]	109	43 (16–74)	–	7 (>69 years)	–
Burnett (1999) [16]	239	n.r. (<14–60+)	12	3	27
Tallman (2002) [18]	300	38 (1–81)	10 (>65 years)	–	–
Ades (2005) [19, 33]	533	46 (32–70)	24	6	–
Sanz (2010) [20]	963	41 (18–70+)	17	6	27
Burnett (2012) [21]	285	42 (16–69)	6	0	21
Lengfelder (2013) [22, 23]	260	51 (16–87)	26	9	28

n.r. not reported